Dallas Diabetes and Endocrine Research Center

Dallas, Texas 75230

0 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type II, Non-alcoholic Steatohepatitis, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus — Completed
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus — Completed
• A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) — Completed
• A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator — Completed